scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1042100538 |
P356 | DOI | 10.1186/1471-2172-7-23 |
P932 | PMC publication ID | 1590050 |
P698 | PubMed publication ID | 16984635 |
P5875 | ResearchGate publication ID | 6809090 |
P50 | author | Gosse J Adema | Q89268769 |
P2093 | author name string | Piet L C M van Riel | |
Timothy R D J Radstake | |||
Robbert van der Voort | |||
B Willem Schreurs | |||
Mieke F Roelofs | |||
Antoine W T van Lieshout | |||
Linda M P le Blanc | |||
P2860 | cites work | Pathogenic role of the CXCL16-CXCR6 pathway in rheumatoid arthritis. | Q54638934 |
Elevated CXCL16 expression by synovial macrophages recruits memory T cells into rheumatoid joints. | Q54664669 | ||
CC Chemokine Ligand 18, An Atopic Dermatitis-Associated and Dendritic Cell-Derived Chemokine, Is Regulated by Staphylococcal Products and Allergen Exposure | Q56966131 | ||
Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions | Q58620040 | ||
Pulmonary and Activation-Regulated Chemokine Stimulates Collagen Production in Lung Fibroblasts | Q60537799 | ||
Selective induction of CCL18/PARC by staphylococcal enterotoxins in mononuclear cells and enhanced levels in septic and rheumatoid arthritis | Q62019515 | ||
Characteristics of human monocytes cultured in the Teflon culture bag | Q71454240 | ||
Quantitative analysis of chemokine expression by dendritic cell subsets in vitro and in vivo | Q73894243 | ||
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention | Q73932709 | ||
Lymphoid neogenesis in rheumatoid synovitis | Q74147962 | ||
The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells | Q80955813 | ||
Serum pulmonary and activation-regulated chemokine/CCL18 levels in patients with systemic sclerosis: a sensitive indicator of active pulmonary fibrosis | Q81162536 | ||
Plasma chitotriosidase and CCL18: early biochemical surrogate markers in type B Niemann-Pick disease | Q81384280 | ||
Interleukin-17 acts independently of TNF-alpha under arthritic conditions | Q83276448 | ||
A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells | Q24311809 | ||
A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes | Q24318783 | ||
The role of T-cell interleukin-17 in conducting destructive arthritis: lessons from animal models | Q24519770 | ||
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes | Q24647107 | ||
Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors | Q24673314 | ||
Interleukin-18: a therapeutic target in rheumatoid arthritis? | Q24799490 | ||
Unique regulation of CCL18 production by maturing dendritic cells | Q28185014 | ||
Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium | Q28216812 | ||
Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern | Q28269475 | ||
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes | Q29547633 | ||
A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers | Q32133166 | ||
Dendritic cells and the pathogenesis of rheumatoid arthritis | Q33712292 | ||
Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group | Q33885648 | ||
Arguments for interleukin 1 as a target in chronic arthritis | Q34071312 | ||
Lymphoid microstructures in rheumatoid synovitis | Q34494488 | ||
Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial | Q34559671 | ||
CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway | Q34652416 | ||
Immature, but not inactive: the tolerogenic function of immature dendritic cells | Q34842360 | ||
Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells. | Q35024786 | ||
Ectopic Germinal Center Formation in Rheumatoid Synovitis | Q35119934 | ||
Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis | Q35553008 | ||
Tumor-associated macrophages and dendritic cells as prototypic type II polarized myeloid populations | Q35660570 | ||
PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia | Q35843496 | ||
Macrophages, synovial tissue and rheumatoid arthritis. | Q40856881 | ||
Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF alpha antibody therapy and its mechanism of action. | Q41207017 | ||
The role of macrophages in chronic arthritis | Q41228313 | ||
Activation of human dendritic cells through CD40 cross-linking. | Q41440958 | ||
Cell culture for three-dimensional modeling in rotating-wall vessels: an application of simulated microgravity | Q41644303 | ||
Inhibition of TNF alpha during maturation of dendritic cells results in the development of semi-mature cells: a potential mechanism for the beneficial effects of TNF alpha blockade in rheumatoid arthritis | Q41809691 | ||
High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering. | Q41987472 | ||
Increased FcgammaRII expression and aberrant tumour necrosis factor alpha production by mature dendritic cells from patients with active rheumatoid arthritis | Q42068422 | ||
Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. | Q46685036 | ||
Differentiation of human dendritic cells from monocytes in vitro. | Q51106538 | ||
CXCL16 is elevated in the cerebrospinal fluid versus serum and in inflammatory conditions with suspected and proved central nervous system involvement. | Q51985595 | ||
The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. | Q52964856 | ||
Distinct patterns and kinetics of chemokine production regulate dendritic cell function. | Q54093362 | ||
P921 | main subject | toll-like receptor | Q408004 |
dendritic cell | Q506253 | ||
P304 | page(s) | 23 | |
P577 | publication date | 2006-09-19 | |
P1433 | published in | BMC Immunology | Q2877163 |
P1476 | title | Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, toll-like receptors and rheumatoid synovial fluid | |
P478 | volume | 7 |
Q35534748 | An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells |
Q41435464 | An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma |
Q41932370 | Azithromycin distinctively modulates classical activation of human monocytes in vitro. |
Q36392394 | Cells of the synovium in rheumatoid arthritis. Dendritic cells. |
Q34051768 | Chemokines and chemokine receptors in arthritis |
Q36013933 | Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis |
Q37598701 | Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis |
Q36794899 | Developments in the synovial biology field 2006. |
Q51781016 | Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion. |
Q36401957 | Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis |
Q36570240 | Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype |
Q35634156 | Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps. |
Q40683161 | Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial |
Q35228824 | Serum and synovial fluid levels of CCL18 are correlated with radiographic grading of knee osteoarthritis |
Q24606039 | The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum |
Search more.